Pharmaceutical companies by today's price change
How far the share price has moved since the previous close.
Spyre Therapeutics leads the 61 pharmaceutical companies ranked by today's price change, at +8.15%, ahead of TG Therapeutics (+5.44%) and BioMarin Pharmaceutical (+4.99%). Figures as of 18 Nov 2026, 21:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Spyre Therapeutics+8.15%
- Median
- -0.83%
- Combined market value
- HK$39.69T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Spyre TherapeuticsSYRE · Health Care | +8.15% | HK$75.6B | HK$795.95 | 8.15% up | 286% up | ||
| 2 | TG TherapeuticsTGTX · Health Care | +5.44% | HK$78.4B | HK$518.71 | 5.44% up | 107% up | ||
| 3 | BioMarin PharmaceuticalBMRN · Health Care | +4.99% | HK$93.3B | HK$481.92 | 4.99% up | 11% up | ||
| 4 | Amneal PharmaceuticalsAMRX · Health Care | +3.60% | HK$59.8B | HK$171.65 | 3.60% up | 83% up | ||
| 5 | Elanco Animal HealthELAN · Health Care | +3.29% | HK$104.7B | HK$209.46 | 3.29% up | 20% up | ||
| 6 | AlkermesALKS · Health Care | +3.08% | HK$61.8B | HK$367.54 | 3.08% up | 58% up | ||
| 7 | Jazz PharmaceuticalsJAZZ · Health Care | +2.93% | HK$124.8B | HK$1,943.76 | 2.93% up | 37% up | ||
| 8 | ZoetisZTS · Health Care | +2.50% | HK$272.8B | HK$671.30 | 2.50% up | 29% down | ||
| 9 | ABIVAXABVX · Health Care | +2.11% | HK$57.6B | HK$657.65 | 2.11% up | 27% down | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | +2.08% | HK$64.7B | HK$933.87 | 2.08% up | 13% up | ||
| 11 | Protagonist TherapeuticsPTGX · Health Care | +2.00% | HK$65.1B | HK$997.57 | 2.00% up | 46% up | ||
| 12 | Ligand PharmaceuticalsLGND · Health Care | +1.67% | HK$46.9B | HK$2,343.38 | 1.67% up | 43% up | ||
| 13 | Ionis PharmaceuticalsIONS · Health Care | +1.59% | HK$35.8B | HK$214.87 | 1.59% up | 64% down | ||
| 14 | BridgeBio PharmaBBIO · Health Care | +1.58% | HK$119.2B | HK$611.99 | 1.58% up | 17% up | ||
| 15 | Dr. Reddy's LaboratoriesRDY · Health Care | +1.28% | HK$98B | HK$117.52 | 1.28% up | 5% up | ||
| 16 | Legend BiotechLEGN · Health Care | +0.87% | HK$24.7B | HK$127.48 | 0.87% up | 42% down | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | +0.59% | HK$47.4B | HK$725.58 | 0.59% up | 31% up | ||
| 18 | Vertex PharmaceuticalsVRTX · Health Care | +0.42% | HK$1.07T | HK$4,208.45 | 0.42% up | 27% up | ||
| 19 | Arrowhead PharmaceuticalsARWR · Health Care | +0.28% | HK$47.8B | HK$338.20 | 0.28% up | 10% up | ||
| 20 | Roivant SciencesROIV · Health Care | +0.05% | HK$220.1B | HK$303.84 | 0.05% up | 90% up | ||
| 21 | Praxis Precision MedicinesPRAX · Health Care | +0.04% | HK$66.9B | HK$2,394.22 | 0.04% up | 61% up | ||
| 22 | Royalty PharmaRPRX · Health Care | -0.01% | HK$309.8B | HK$538.72 | 0.01% down | 78% up | ||
| 23 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | -0.06% | HK$58.6B | HK$745.67 | 0.06% down | 126% up | ||
| 24 | Cogent BiosciencesCOGT · Health Care | -0.14% | HK$38B | HK$218.17 | 0.14% down | 20% down | ||
| 25 | PTC TherapeuticsPTCT · Health Care | -0.22% | HK$39.5B | HK$472.50 | 0.22% down | 20% down | ||
| 26 | Abbott LaboratoriesABT · Health Care | -0.22% | HK$1.42T | HK$819.65 | 0.22% down | 17% down | ||
| 27 | Ascendis PharmaASND · Health Care | -0.32% | HK$139.1B | HK$2,120.74 | 0.32% down | 28% up | ||
| 28 | Oruka TherapeuticsORKA · Health Care | -0.60% | HK$50.9B | HK$751.08 | 0.60% down | 241% up | ||
| 29 | VeradermicsMANE · Health Care | -0.62% | HK$41.3B | HK$979.53 | 0.62% down | 233% up | ||
| 30 | CytokineticsCYTK · Health Care | -0.64% | HK$56.1B | HK$402.61 | 0.64% down | 20% down | ||
| 31 | ViatrisVTRS · Health Care | -0.83% | HK$182.4B | HK$159.10 | 0.83% down | 96% up | ||
| 32 | SanofiSNY · Health Care | -0.86% | HK$887.6B | HK$369.66 | 0.86% down | 4% down | ||
| 33 | Definium TherapeuticsDFTX · Health Care | -0.88% | HK$31.3B | HK$228.45 | 0.88% down | 169% up | ||
| 34 | Teva Pharmaceutical IndustriesTEVA · Health Care | -0.92% | HK$386.6B | HK$331.29 | 0.92% down | 74% up | ||
| 35 | ErascaERAS · Health Care | -0.94% | HK$37.9B | HK$107.95 | 0.94% down | 403% up | ||
| 36 | Belite BioBLTE · Health Care | -0.94% | HK$49.8B | HK$1,225.62 | 0.94% down | 31% up | ||
| 37 | United TherapeuticsUTHR · Health Care | -1.16% | HK$192.9B | HK$4,529.23 | 1.16% down | 23% up | ||
| 38 | Regeneron PharmaceuticalsREGN · Health Care | -1.28% | HK$767.3B | HK$7,417.68 | 1.28% down | 36% up | ||
| 39 | GSKGSK · Health Care | -1.34% | HK$763.9B | HK$381.11 | 1.34% down | 6% up | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | -1.43% | HK$55.3B | HK$1,051.23 | 1.43% down | 7% down | ||
| 41 | PfizerPFE · Health Care | -1.44% | HK$1.25T | HK$220.13 | 1.44% down | 14% up | ||
| 42 | Summit TherapeuticsSMMT · Health Care | -1.59% | HK$65.9B | HK$82.37 | 1.59% down | 36% down | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | -1.59% | HK$35.5B | HK$324.55 | 1.59% down | 88% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | -1.68% | HK$37.8B | HK$394.13 | 1.68% down | 44% up | ||
| 45 | InsmedINSM · Health Care | -1.69% | HK$206.2B | HK$939.83 | 1.69% down | 40% down | ||
| 46 | Takeda PharmaceuticalTAK · Health Care | -1.71% | HK$533.1B | HK$166.86 | 1.71% down | 54% up | ||
| 47 | GrifolsGRFS · Health Care | -1.85% | HK$45.2B | HK$66.45 | 1.85% down | 1% up | ||
| 48 | GenmabGMAB · Health Care | -1.91% | HK$246.6B | HK$399.86 | 1.91% down | 70% up | ||
| 49 | AstraZenecaAZN · Health Care | -1.93% | HK$2.17T | HK$1,402.37 | 1.93% down | 2% up | ||
| 50 | Johnson & JohnsonJNJ · Health Care | -2.15% | HK$5.15T | HK$2,139.33 | 2.15% down | 38% up | ||
| 51 | Eli LillyLLY · Health Care | -2.32% | HK$9.66T | HK$10,847.67 | 2.32% down | 35% up | ||
| 52 | AbbVieABBV · Health Care | -2.33% | HK$3.97T | HK$2,243.75 | 2.33% down | 26% up | ||
| 53 | BeOne MedicinesONC · Health Care | -2.34% | HK$361.7B | HK$3,166.24 | 2.34% down | 17% up | ||
| 54 | NovartisNVS · Health Care | -2.46% | HK$2.3T | HK$1,217.62 | 2.46% down | 25% up | ||
| 55 | Bristol-Myers SquibbBMY · Health Care | -2.92% | HK$955.1B | HK$467.25 | 2.92% down | 34% up | ||
| 56 | Novo NordiskNVO · Health Care | -3.12% | HK$1.36T | HK$309.33 | 3.12% down | 17% down | ||
| 57 | Corcept TherapeuticsCORT · Health Care | -3.25% | HK$58.2B | HK$531.81 | 3.25% down | 8% down | ||
| 58 | Dianthus TherapeuticsDNTH · Health Care | -3.45% | HK$37.1B | HK$658.82 | 3.45% down | 113% up | ||
| 59 | Merck & CoMRK · Health Care | -3.90% | HK$2.66T | HK$1,080.88 | 3.90% down | 51% up | ||
| 60 | Alnylam PharmaceuticalsALNY · Health Care | -4.54% | HK$157B | HK$1,172.04 | 4.54% down | 66% down | ||
| 61 | Madrigal PharmaceuticalsMDGL · Health Care | -5.67% | HK$72.5B | HK$3,122.94 | 5.67% down | 24% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 7.8450 HKD).
Questions and answers
Which pharmaceutical companies rank first by today's price change?
Spyre Therapeutics (+8.15%), TG Therapeutics (+5.44%) and BioMarin Pharmaceutical (+4.99%) are the top three of the 61 pharmaceutical companies ranked by today's price change as of 18 Nov 2026, 21:48 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by today's price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by today's price change have a combined market value of HK$39.69T as of 18 Nov 2026, 21:48 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.